(S)-6-(Hydroxymethyl)piperidin-2-one is a chiral piperidinone derivative featuring both a hydroxymethyl group and a lactam (cyclic amide) functionality. This compound serves as a versatile and important chiral building block in pharmaceutical synthesis. Its structure combines a nitrogen-containing heterocycle with a handle for further chemical modification, making it valuable for constructing complex bioactive molecules. The primary application of this compound is as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It is notably utilized in the production of HIV protease inhibitors, such as Atazanavir and Darunavir, where the chiral piperidinone core is a critical structural component. The hydroxymethyl group allows for selective functionalization, enabling chemists to attach other pharmacophores or linkers during drug development. As a chiral synthon, it is employed in medicinal chemistry research for exploring structure-activity relationships and developing new therapeutic agents targeting viral infections and other diseases. Its utility underscores its role in the synthesis of high-value, stereochemically defined pharmaceutical compounds.